Page 41 Volume 20 - N2 - 2012

Dor (2012) 20
3. Biessels G. Diabetic encephalopathy. Em: Veves A, Malik R, eds. 21. Burchiel KJ, Russell LC, Lee RP, Sima AA. Spontaneous activity of
a
Diabetic neuropathy: clinical management. 2. ed. Humana Press; primary afferent neurons in diabetic BB/Wistar rats. A possible mecha-
2007. nism of chronic diabetic neuropathic pain. Diabetes. 1985;34:1210-3.
4. Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability 22. Ahlgren SC, Levine JD. Protein kinase C inhibitors decrease hyper-
and enlarged receptive fields in the STZ model of diabetic pain. algesia and C-fiber hyperexcitability in the streptozotocin-diabetic
Brain Res. 2009;1268:154-61. rat. J Neurophysiol. 1994;72:684-92.
5. Morgado C, Tavares I. C-fos expression at the spinal dorsal horn of 23. D’Mello R, Dickenson AH. Spinal cord mechanisms of pain. Br J
streptozotocin induced diabetic rats. Diabetes Metab Res Rev. 2007; Anaesth. 2008;101:8-16.
23:644-52. 24. Li N, Young MM, Bailey CJ, Smith ME. NMDA and AMPA glutamate © Permanyer Portugal 2012
6. Morgado C, Terra PP, Tavares I. Neuronal hyperactivity at the spinal receptor subtypes in the thoracic spinal cord in lean and obese-
cord and periaqueductal grey during painful diabetic neuropathy: diabetic ob/ob mice. Brain Res. 1999;849:34-44.
Effects of gabapentin. Eur J Pain. 2010;14:693-9. 25. Kamei J, Ogawa M, Kasuya Y. Development of supersensitivity to
7. Pertovaara A, Wei H, Kalmari J, Ruotsalainen M. Pain behavior and substance P in the spinal cord of the streptozotocin-induced dia-
response properties of spinal dorsal horn neurons following experimen- betic rats. Pharmacol Biochem Behav. 1990;35:473-5.
tal diabetic neuropathy in the rat: modulation by nitecapone, a COMT 26. Chen SR, Sweigart KL, Lakoski JM, Pan HL. Functional mu opioid
inhibitor with antioxidant properties. Exp Neurol. 2001;167:425-34. receptors are reduced in the spinal cord dorsal horn of diabetic rats.
8. Chen SR, Pan HL. Hypersensitivity of spinothalamic tract neurons Anesthesiology. 2002;97:1602-8.
associated with diabetic neuropathic pain in rats. J Neurophysiol. 27. Williams J, Haller VL, Stevens DL, Welch SP. Decreased basal en-
2002;87:2726-33. dogenous opioid levels in diabetic rodents: effects on morphine and
9. Morgado C, Silva L, Pereira-Terra P, Tavares I. Changes in serotonin- delta-9-tetrahydrocannabinoid-induced antinociception. Eur J Phar-
ergic and noradrenergic descending pain pathways during painful macol. 2008;584:78-86.
diabetic neuropathy: the preventive action of IGF1. Neurobiol Dis. 28. Jolivalt CG, Lee CA, Ramos KM, Calcutt NA. Allodynia and hyper-
2011;43: 275-84. algesia in diabetic rats are mediated by GABA and depletion of
10. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy spinal potassium-chloride cotransporters. Pain. 2008;140:48-57.
Expert Group. Diabetic neuropathies: update on definitions, diag- 29. Malcangio M, Bowery NG. GABA and its receptors in the spinal cord.
nostic criteria, estimation of severity, and treatments. Diabetes Care. Trends Pharmacol Sci. 1996;17:457-62.
2010;33:2285-93. 30. Payne J, Rivera C, Voipio J, Kaila K. Cation-chloride cotransporters
11. Tracey I, Mantyh PW. The cerebral signature for pain perception and in neuronal communication, development and trauma. Trends Neu-
its modulation. Neuron. 2007;55:377-91. rosci. 2003;26:199-206.
12. Vanegas H, Schaible HG. Descending control of persistent pain: 31. Morgado C, Pinto-Ribeiro F, Tavares I. Diabetes affects the expression
inhibitory or facilitatory? Brain Res Rev. 2004;46:295-309. of GABA and potassium chloride cotransporter in the spinal cord: a
13. Ribeiro da Silva A. Substantia gelatinosa of the spinal cord. Em: study in streptozotocin diabetic rats. Neurosci Lett. 2008;438:102-6.
Paxinos G, ed. The rat nervous system. 3. ed. Elsevier Academic 32. Morgado C, Pereira-Terra P, Cruz CD, Tavares I. Minocycline com-
a
Press; 2004. pletely reverses mechanical hyperalgesia in diabetic rats through
14. Behbehani MM. Functional characteristics of the midbrain periaque- microglia-induced changes in the expression of the potassium chlo-
ductal gray. Prog Neurobiol. 1995;46:575-605. ride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes
15. Keay KA, Bandler R. Periaqueductal gray. Em: Paxinos G, ed. The Metab. 2011;13:150-9.
a
rat nervous system. 3. ed. Elsevier Academic Press; 2004. 33. Morgado C, Pereira-Terra P, Tavares I. Alpha-lipoic acid normalizes
16. Bajic D, Proudfit HK. Projections of neurons in the periaqueductal nociceptive neuronal activity at the spinal cord of diabetic rats. Dia-
gray to pontine and medullary catecholamine cell groups involved betes Obes Metab. 2011;13:736-41.
in the modulation of nociception. J Comp Neurol. 1999;405:359-79. 34. Price T, Cervero F, De Koninck Y. Role of cation-chloride cotransporters
17. Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control (CCC) in pain and hyperalgesia. Curr Top Med Chem. 2005;5:547-55.
of nociception: Specificity, recruitment and plasticity. Brain Res Rev. 35. Wang XL, Zhang HM, Chen SR, Pan HL. Altered synaptic input and
2009;60:214-25. GABAB receptor function in spinal superficial dorsal horn neurons
18. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. in rats with diabetic neuropathy. J Physiol. 2007;579:849-61.
2006;80:53-83. 36. Wang XL, Zhang Q, Zhang YZ, et al. Downregulation of GABAB
19. Finnerup NB, Sindrup SH, Jensen TD. The evidence for pharmaco- receptors in the spinal cord dorsal horn in diabetic neuropathy.
logical treatment of neuropathic pain. Pain. 2010;150:573-81. Neurosci Lett. 2011;490:112-5.
20. Tesfaye S. Advances in the management of diabetic peripheral 37. Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Sem o consentimento prévio por escrito do editor, não se pode reproduzir nem fotocopiar nenhuma parte desta publicação.
neuropathy. Curr Opin Support Palliat Care. 2009;3:136-43. Clin Invest. 2010;120:3779-87.

DOR

40